Treatment of the following infections by ofloxacin-susceptible strains of Staphylococcus, Streptococcus and Proteus spp, Pseudomonas aeruginosa and Haemophilus influenzae.
Chronic suppurative otitis media, otitis media with tympanostomy tube, otitis externa.